BondBloxx USD High Yield Bond Healthcare Sector ETF (XHYH) seeks to track high-yield corporate bonds issued by healthcare companies, focusing on below-investment-grade debt securities from pharmaceutical, biotechnology, medical device, and healthcare services firms. This sector-specific fixed income ETF targets higher yields through credit risk exposure within healthcare industry bonds.
How It Works
XHYH employs a passive indexing approach that holds USD-denominated high-yield bonds from healthcare sector issuers, typically rated BB+ or below by major credit agencies. The fund maintains sector focus while diversifying across healthcare subsectors including pharmaceuticals, biotech, medical devices, and healthcare REITs. Portfolio construction emphasizes yield generation through credit risk rather than duration risk, with regular rebalancing to maintain healthcare sector exposure and credit quality parameters.
Key Features
- Unique sector-specific high-yield bond exposure combining healthcare industry focus with below-investment-grade credit risk for enhanced yields
- Attractive 5.80% dividend yield from healthcare companies' higher-risk debt securities, paid monthly to investors
- Newer ETF launched in 2022 providing targeted access to previously hard-to-reach healthcare high-yield bond market segment
Risks
- This ETF can lose value if healthcare companies default on bonds or face credit downgrades, with potential losses of 20-40% during healthcare sector stress
- Rising interest rates reduce bond values, though shorter duration high-yield bonds typically show less sensitivity than investment-grade alternatives
- Economic recessions disproportionately impact high-yield bonds as credit spreads widen and default rates increase across all sectors including healthcare
Who Should Own This
Best suited for income-focused investors with medium-to-high risk tolerance seeking 3-5 year holding periods and monthly dividend income. Appropriate as 5-15% satellite allocation within diversified bond portfolios. Ideal for investors bullish on healthcare sector fundamentals who can tolerate credit risk volatility in exchange for higher yields than investment-grade alternatives.